Streetbeat News

Products Services

TNXP

Tonix Pharmaceuticals announced that the new definition of Long COVID by the U.S. National Academies could expand the market for its fibromyalgia treatment, Tonmya. This could increase the addressable market size for Tonmya, which is currently under development with a target NDA submission in the second half of 2024 and potential FDA approval in 2025.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 12:16 pm

MNDY

Monday.com has announced the full release of its Portfolio Management Solution, which includes new capabilities aimed at enhancing strategic initiative management, streamlining operations, and boosting productivity across teams and departments.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 12:15 pm

CUTR

Cutera has announced a partnership with L'Oréal Japan to exclusively promote, market, sell, and distribute SkinCeuticals to clinics in Japan.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 12:15 pm

AMD

TSM

Shares of Taiwan Semiconductor Manufacturing Co. Ltd. (TSMC) are surging in premarket trading due to industry-wide optimism from AMD's quarterly results and increased capex spending by AI-levered mega-caps. TSMC's ADRs had previously lost about 20% from their July highs.

Portfolio Pulse from Shanthi Rexaline

July 31, 2024 | 12:11 pm

GRFS

GigaGen, a subsidiary of Grifols, has received FDA clearance for its IND application to initiate a Phase 1 trial for GIGA-2339, a recombinant polyclonal therapeutic aimed at treating chronic hepatitis B virus (HBV) infection. The trial is expected to start in Q4 2024.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 12:10 pm

ACHV

Achieve Life Sciences announced that the FDA has granted Breakthrough Therapy Designation for its smoking cessation drug, Cytisinicline. This designation is expected to expedite the development and review process of the drug.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 12:10 pm

ASC

Ardmore Shipping reported that 95% of its MR tankers' revenue days in Q3 are employed in the spot market, with the remaining 5% on time charters. The company expects all revenue days for its Eco-Design IMO 2 product/chemical tankers to be employed in the spot market.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 12:06 pm

BWA

BorgWarner has secured its largest North American eFan contract for a high-voltage system on heavy- and medium-duty battery electric vehicles (BEVs). The eFan can reach up to 10 kW power and 40 Nm torque and is liquid-cooled for reliability. Production is set to start in Q4 2027.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 12:02 pm

JNVR

Janover's new insurtech platform has achieved profitability in its second month of operation and increased recurring revenue by more than 60% for May.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 12:00 pm

ATAI

CMPS

CYBN

MNMD

MYCOF

RVVTF

SEEL

PATOO, a Jamaica-based psychedelic CPG brand, has partnered with Fontana Pharmacy to introduce the first legal psilocybin-infused products to Jamaican pharmacy shelves. This move marks a significant step toward broader acceptance of psychedelic wellness products. Several publicly traded companies are at the forefront of developing and commercializing psychedelic therapies, including Compass Pathways, Atai Life Sciences, Cybin Inc., Mind Medicine, Mydecine Innovations Group, Seelos Therapeutics, and Revive Therapeutics.

Portfolio Pulse from Javier Hasse

July 31, 2024 | 12:00 pm